about
Type I interferons for induction of remission in ulcerative colitisChemotherapeutic agents for the treatment of hepatocellular carcinoma: efficacy and mode of actionPulmonary arterial hypertension associated with interferon therapy: a population-based studyFuture of liver disease in the era of direct acting antivirals for the treatment of hepatitis CEbola Virus Infection: Review of the Pharmacokinetic and Pharmacodynamic Properties of Drugs Considered for Testing in Human Efficacy Trials.Cytokine Activation by Antibody Fragments Targeted to Cytokine-Receptor Signaling Complexes.Risk of echocardiographic pulmonary hypertension in individuals with human immunodeficiency virus-hepatitis C virus coinfection.The Concise Guide to PHARMACOLOGY 2013/14: catalytic receptors.Peginterferon alfa-2a is associated with elevations in alanine aminotransferase at the end of treatment in chronic hepatitis C patients with sustained virologic responsePlasmacytoid dendritic cell-derived IFN-α promotes murine liver ischemia/reperfusion injury by induction of hepatocyte IRF-1.Regulatory effects of SKAR in interferon α signaling and its role in the generation of type I IFN responses.Durable remission of mantle cell lymphoma relapsing a third time after allogeneic hematopoietic stem cell transplantation treated with rituximab, bortezomib, donor lymphocytes, and pegylated interferon.Adenosine triphosphate hydrolysis reduces neutrophil infiltration and necrosis in partial-thickness scald burns in miceInterferon-λ1 linked to a stabilized dimer of Fab potently enhances both antitumor and antiviral activities in targeted cells.Interferon-β produces synergistic combinatory anti-tumor effects with cisplatin or pemetrexed on mesothelioma cells.Effect and safety of interferon for hepatocellular carcinoma: a systematic review and meta-analysis.Subtenon injection of natural leukocyte interferon α-2a in diabetic macular edema: a case report.Interferon-λ4 (IFNL4) transcript expression in human liver tissue samples.Role of prostacyclin in pulmonary hypertension.A distinct pre-existing inflammatory tumour microenvironment is associated with chemotherapy resistance in high-grade serous epithelial ovarian cancer.Interferon-β suppresses murine Th1 cell function in the absence of antigen-presenting cells.Impact of hepatitis C virus eradication on hepatocellular carcinogenesis.A RIG-I 2CARD-MAVS200 Chimeric Protein Reconstitutes IFN-β Induction and Antiviral Response in Models Deficient in Type I IFN Response.Reversible pulmonary arterial hypertension associated with interferon-beta treatment for multiple sclerosis.PARP9-DTX3L ubiquitin ligase targets host histone H2BJ and viral 3C protease to enhance interferon signaling and control viral infectionEffect of different interferonα2 preparations on IP10 and ET-1 release from human lung cells.Rapid Detection of Neutrophil Oxidative Burst Capacity is Predictive of Whole Blood Cytokine ResponsesDesign and evaluation of novel interferon lambda analogs with enhanced antiviral activity and improved drug attributes.Sprouty proteins are negative regulators of interferon (IFN) signaling and IFN-inducible biological responsesInterferon γ (IFNγ) Signaling via Mechanistic Target of Rapamycin Complex 2 (mTORC2) and Regulatory Effects in the Generation of Type II Interferon Biological ResponsesEndothelin-1 as a mediator and potential biomarker for interferon induced pulmonary toxicity.Effector T Cells and Ischemia-Induced Systemic Angiogenesis in the Lung.Promising systemic immunotherapies in head and neck squamous cell carcinoma.Immunology. An interferon paradoxIntra-abdominal localisation of a buschke-lowenstein tumour: case presentation and review of the literature.Production of recombinant immunotherapeutics for anticancer treatment: the role of bioengineering.JUNB/AP-1 controls IFN-γ during inflammatory liver disease.ISG15 in the tumorigenesis and treatment of cancer: An emerging role in malignancies of the digestive system.Evidence for the involvement of type I interferon in pulmonary arterial hypertension.Hope and fear for interferon: the receptor-centric outlook on the future of interferon therapy.
P2860
Q24187202-348250D1-BE6B-4AB4-B229-7B3F3FBF2EF7Q27693179-6FBFA006-350B-47B0-80EC-3BBE504CCB3FQ28468304-563095E8-B562-467A-9D3D-494720CAFF63Q30235178-EA2F5C84-8707-45EA-A8A0-91105E062C5FQ30251949-A94CBBD4-9B22-4D77-8F19-C9E15AEC9B69Q30381154-5E03F000-A147-438B-9885-F5D88D6E57B4Q30397068-E8D27FC5-1BB9-4B69-A269-E5B658572653Q30486741-ACEC4C8F-8DED-4F99-90CD-871488AECE73Q33769085-DAE0E3C2-B43B-410D-AE50-4ABF0CC4581DQ33831458-A8B415B8-D9B1-485E-B942-2B08C526C36CQ34025462-B2C762FF-BECA-44BB-9442-DBCE1ED2F3E4Q34096874-452A376A-5224-4734-BF31-2D818B27635AQ34122808-9FCC6248-6503-49E1-A79A-D5D6D6B2DFD9Q34734013-94CBCD7D-41EE-43C3-B827-E8BF963537B4Q34974037-9C9029A1-AFB7-4CB6-A530-9419F2075979Q34998414-AA881C79-E0B5-49E2-A8F3-6B2E781439A8Q35027317-4EF4A70F-09DF-4C63-AADF-15E393BAB583Q35078322-8B60342E-85B3-41E2-9268-6DBC0ED58F10Q35165100-FC7897ED-246B-4DE1-8BC3-DECA9810514CQ35274995-2121FC15-D970-4BFA-86B7-81D355965A4EQ35461764-25AA732B-594C-460D-8DA6-321809C60420Q35985401-211FBBE0-E32F-46B5-9FCC-58F0B9EE887DQ36005999-33390003-4402-4CAF-9E46-F6E6151E6660Q36132177-C7A14B94-2385-4E08-8E9E-D2766361B8DAQ36299937-A7CA4A28-6795-4350-BC11-2DF47B8CEF86Q36303468-F3AF1650-C310-4BFF-BEDC-AF4F3D420ECDQ36418414-D35E7531-EB01-4FFC-B1EA-D5A1AE788EC2Q36450748-6769FFFA-8959-4907-B3A9-E780CC18CBF7Q36452049-9FD3A1B3-8A0F-4C87-B6BF-2D09DDD96F1FQ36518337-424C1B54-DFCD-46E1-AF66-48D0BF6DBD13Q36563591-380394EF-427C-433D-BCEE-6BD8CA1A91AAQ36765887-2E724B1F-CBEC-4BB0-899C-A8E0FE8A1B68Q36883848-EA9EFA09-66D0-4C81-BF70-735286D67276Q36949540-A8D25D7F-5047-486E-83B0-547F6BC74286Q37212549-4E5EC77E-740D-4683-81DB-FC7C40CD3C8BQ37269115-912D1122-D435-484B-BE2C-A7DED0819060Q37384060-57300B49-7109-4216-AF4F-BFBFBC238B0EQ37687572-7F9D0692-D5FA-4433-A7CE-81E2B3474993Q37735087-F5B722E8-4B3D-4BCB-B0E3-4A27FF1A4FF0Q38097519-00FABF9D-1956-43A0-9AEE-41CAC09600EF
P2860
description
article científic
@ca
article scientifique
@fr
articol științific
@ro
articolo scientifico
@it
artigo científico
@gl
artigo científico
@pt
artigo científico
@pt-br
artikel ilmiah
@id
artikull shkencor
@sq
artículo científico
@es
name
Pharmacology and therapeutic potential of interferons.
@en
type
label
Pharmacology and therapeutic potential of interferons.
@en
prefLabel
Pharmacology and therapeutic potential of interferons.
@en
P2093
P1476
Pharmacology and therapeutic potential of interferons.
@en
P2093
Graham R Foster
Jane A Mitchell
Peter M George
Rekha Badiger
William Alazawi
P356
10.1016/J.PHARMTHERA.2012.03.006
P577
2012-03-28T00:00:00Z